Measurement properties of three assessments of burden used in atopic dermatitis in adults
- PMID: 30246360
- PMCID: PMC6431274
- DOI: 10.1111/bjd.17243
Measurement properties of three assessments of burden used in atopic dermatitis in adults
Abstract
Background: Standardized quality-of-life (QoL) assessments can provide important and clinically relevant information. There is currently a lack of standardization in QoL assessments used in atopic dermatitis (AD).
Objectives: To determine the content validity, construct validity, internal consistency, differential reporting, responsiveness, floor or ceiling effects and feasibility of the Dermatology Life Quality Index (DLQI), Itchy Quality of Life (ItchyQoL) and 5-dimensions (5-D) itch scales for assessing burden of AD in adults and to compare their performance.
Methods: Self-administered questionnaires and skin examination were performed in 340 adults with AD in a dermatology practice setting.
Results: DLQI, ItchyQoL and 5-D all had good content validity. DLQI, mean ItchyQoL and 5-D itch all had strong correlations with frequency of AD symptoms (Patient-Oriented Eczema Measure) and intensity of itch (numerical rating scale for itch), and moderate correlations with AD severity (Eczema Area and Severity Index and Scoring Atopic Dermatitis) (Spearman correlations, P < 0·001 for all). DLQI and 5-D itch showed good internal consistency (Cronbach's alpha = 0·89 and 0·84), although ItchyQoL appeared to have several redundant items (alpha = 0·96). Uniform and nonuniform differential item functioning by age, sex and/or race/ethnicity was found for multiple items in DLQI, ItchyQoL and 5-D itch. DLQI, ItchyQoL and 5-D itch scores all demonstrated responsiveness, although ItchyQoL demonstrated the greatest responsiveness. There were no floor or ceiling effects for total scores. The median times for completion of DLQI, ItchyQoL and 5-D itch were 2 min.
Conclusions: The DLQI, ItchyQoL and 5-D itch scales all showed good content and construct validity, and responsiveness in the assessment of AD in adults, and were feasible for use in clinical trials and practice.
© 2018 British Association of Dermatologists.
Conflict of interest statement
Conflicts of interest: None
Comment in
-
Good evidence on measurement properties of the Dermatology Life Quality Index, Itchy Quality of Life and 5-dimensions itch scales in atopic eczema, but problems with structural validity remain.Br J Dermatol. 2019 May;180(5):979-980. doi: 10.1111/bjd.17761. Br J Dermatol. 2019. PMID: 31025750 No abstract available.
References
-
- Haeck IM, ten Berge O, van Velsen SG et al. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV 2012; 26: 236–41. - PubMed
-
- Simpson EL, Bruin-Weller M, Flohr C et al. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. Journal of the American Academy of Dermatology 2017; 77: 623–33. - PubMed
-
- Chalmers JR, Simpson E, Apfelbacher CJ et al. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). The British journal of dermatology 2016; 175: 69–79. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials